Making correct lifestyle choices, from exercising to drinking less alcohol, can reduce risk of heart diseases and cancer ...

Roche said it plans to focus on five key therapeutic areas as part of its new pharma strategy through 2030. The company will prioritize work in the areas of neurology, oncology and hematology, ...

Roche said it plans to focus on five key therapeutic areas as part of its new pharma strategy through 2030. The company will prioritize work in the areas of neurology, oncology and hematology, ...

Exploding sales of prescription weight loss medications have catapulted Novo Nordisk (NVO) and Eli Lilly (LLY) to become the ...

Tom Arnold revealed how he lost 80 pounds without taking Ozempic. Arnold began working with fitness guru Charles D'Angelo in ...

Amgen's strong dividend growth, with a 2.8% yield and consistent hikes since 2011. Read what makes AMGN stock is a worthy ...

GLP-1 medicines like Ozempic, Wegovy, and Zepbound – popular across the US, help you shed pounds, but only if taken properly.

Ongoing shortages of popular weight loss and diabetes drugs in the U.S. have spurred fierce competition between established drugmakers and an emerging market of compounded versions as telehealth ...

Some business leaders might be tested in having to respond to the different challenges and crisis situations that have ...

Congress is pushing companies like Ozempic and Wegovy, which make weight loss drugs that have changed the lives of millions ...

Weight-loss drugs like Ozempic and Wegovy have become household names in recent years. But here's why they may not work for ...

NEW YORK – WeightWatchers is shaking up its leadership. WW International announced Friday that CEO Sima Sistani would leave ...